User profiles for Doo-Ho Lim
 | Doo Ho LimDivision of Rheumatology, Department of Internal Medicine, Ulsan University Hospital … Verified email at uuh.ulsan.kr Cited by 391 |
[HTML][HTML] A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient
YH Jeon, DH Lim, SW Choi, SJ Choi - Rheumatology International, 2022 - Springer
Vaccination is a cornerstone for reducing the risk of COVID-19 infection during a pandemic.
Although the currently used COVID-19 vaccine is considered safe, some concerns persist …
Although the currently used COVID-19 vaccine is considered safe, some concerns persist …
[HTML][HTML] Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying …
…, SW Choi, KW Seo, S Lee, MW So, DH Lim - Rheumatology …, 2020 - Springer
In December 2019, numerous coronavirus disease 2019 (COVID-19) cases were reported
in Wuhan, China, which has since spread throughout the world. However, its impact on …
in Wuhan, China, which has since spread throughout the world. However, its impact on …
Serum uric acid level and subclinical coronary atherosclerosis in asymptomatic individuals: an observational cohort study
DH Lim, Y Lee, GM Park, SW Choi, YG Kim, SW Lee… - Atherosclerosis, 2019 - Elsevier
Background and aims There are limited data on the association between serum uric acid (SUA)
level and subclinical coronary atherosclerosis. This study investigated the influence of …
level and subclinical coronary atherosclerosis. This study investigated the influence of …
[PDF][PDF] Febuxostat in hyperuricemic patients with advanced CKD
RESEARCH LETTERS Page 1 as independent risk factors for AKI and adverse outcomes
after cardiac and noncardiac surgeries.Thus, we argue that not taking intra- and postoperative …
after cardiac and noncardiac surgeries.Thus, we argue that not taking intra- and postoperative …
[HTML][HTML] Changing patterns of medical visits and factors associated with no-show in patients with rheumatoid arthritis during COVID-19 pandemic
Y Kim, E Ahn, S Lee, DH Lim, A Kim… - Journal of Korean …, 2020 - ncbi.nlm.nih.gov
Background The main barrier to the effective rheumatoid arthritis (RA) therapy is poor
adherence. Coronavirus disease 2019 (COVID-19) pandemic have led to a significant change in …
adherence. Coronavirus disease 2019 (COVID-19) pandemic have led to a significant change in …
The risk of herpes zoster in patients with ankylosing spondylitis: analysis of the Korean National Health Insurance Service–sample cohort database
DH Lim, YJ Kim, SO Kim, S Hong, CK Lee… - Modern …, 2018 - academic.oup.com
Objectives: The aims of our study were to determine whether the use of conventional
disease-modifying antirheumatic drugs (cDMARDs) or tumor necrosis factor α (TNFα) inhibitors …
disease-modifying antirheumatic drugs (cDMARDs) or tumor necrosis factor α (TNFα) inhibitors …
[HTML][HTML] Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus
Methods The medical records of patients diagnosed with SLE-associated ATM between
January 1995 and January 2015 were reviewed. The patients were divided into two groups …
January 1995 and January 2015 were reviewed. The patients were divided into two groups …
[HTML][HTML] Effect of tumor necrosis factor inhibition on spinal inflammation and spinal ankylosis in SKG mice
To prevent spinal progression in ankylosing spondylitis, initiating TNF-inhibitor treatment as
early as possible is suggested. However, the outcomes are inconsistent in previous clinical …
early as possible is suggested. However, the outcomes are inconsistent in previous clinical …
[PDF][PDF] Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes
Objective. The aim of this study was to determine whether adult IgA vasculitis patients who
developed the disease at an older age differ from early-onset patients in terms of clinical …
developed the disease at an older age differ from early-onset patients in terms of clinical …
[HTML][HTML] Immunoglobulin binding protein 1 as a potential urine biomarker in patients with lupus nephritis
We evaluated the role of immunoglobulin binding protein 1 (IGBP1), a phosphoprotein
associated with the B cell receptor (BCR) complex, as a urine biomarker in lupus nephritis (LN). …
associated with the B cell receptor (BCR) complex, as a urine biomarker in lupus nephritis (LN). …